title: Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
abstract: The influence of cryoprecipitate (CP) on liver histology and peripheral titers of hepatitis C virus (HCV) RNA was evaluated for 115 patients with chronic hepatitis. Fifty-four patients had measurable CP levels whereas 61 did not. Assessment of liver biopsies for grade of fibrosis revealed that patients with CP had increased fibrosis (P <.001) and incidence of cirrhosis (P =.001) compared with those without CP. In contrast, there was not a significant difference in the inflammatory activity score between the 2 groups. HCV RNA in whole blood (WB) and plasma (Pl) was evaluated in patients with or without CP by end-point-limiting dilution titer. Among patients with CP, WB titers were significantly higher than Pl titers (P <.001); however, there was no difference in WB or Pl titers in patients without CP (P =.068). Histological activity and fibrosis scores of patients from either group were compared with peripheral viral titers of WB and Pl, percentage of CP, rheumatoid factor (RF) titer, and serum alanine transaminase (ALT). There were significant correlations between the amount of fibrosis and the percentage of CP and rheumatoid factor titer, yet neither of the latter parameters was correlated with inflammatory activity. These data suggest that patients with CP and chronic hepatitis owing to HCV are more likely to have progressive disease than patients without CP. Furthermore, the presence of CP in patients infected with HCV appears to influence the amount of virus detected in patient Pl, suggesting that WB assays may be more reliable for HCV-RNA quantitation in patients with CP.
authors.affiliation: Department of Internal Medicine, The University of Iowa College of Medicine, Iowa City, IA 52242-1081, USA. warren-schmidt@uiowa.edu
authors.forename: W N
authors.initials: WN
authors.lastname: Schmidt
authors.forename: J T
authors.initials: JT
authors.lastname: Stapleton
authors.forename: D R
authors.initials: DR
authors.lastname: LaBrecque
authors.forename: F A
authors.initials: FA
authors.lastname: Mitros
authors.forename: P A
authors.initials: PA
authors.lastname: Kirby
authors.forename: M J
authors.initials: MJ
authors.lastname: Phillips
authors.forename: D L
authors.initials: DL
authors.lastname: Brashear
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D003449:Cryoglobulinemia / Q000150:complications*; D005260:Female; D005355:Fibrosis; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications* / Q000821:virology; D006801:Humans; D008099:Liver / Q000473:pathology* / Q000821:virology; D008103:Liver Cirrhosis / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood*; D012217:Rheumatoid Factor / Q000097:blood
chemical_list: D012367:RNA, Viral; D012217:Rheumatoid Factor; D000410:Alanine Transaminase